ForecastedNational Institutes of Health

Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier

Opportunity number RFA-HD-28-003 · Assistance listing 93.865

Estimated deadline
Oct 20, 2027
Expected posting
Jul 16, 2026
Award size
Not listed
Total program funding
$3M
Expected awards
Not listed
Cost sharing
Not required
Funding type
Grant
Category
Health

Check this solicitation free

Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.

About this opportunity

The Eunice Kennedy Shriver National Institute of Child Health and Human Development seeks to advance its mission of supporting maternal, fetal, and child health by continuing to enhance the understanding of maternal, fetal, and child exposure to nutrients, metabolites, medications, supplements, microbiome-derived products, and environmental chemicals. This will be done by supporting a second phase of the Transporter Elucidation Network (TEN). This phase of the TEN will establish perinatal multi-barrier transport network frameworks to clarify how transporters and local biotransformation regulate these processes. Building on prior organ-focused models, methods, and datasets, this initiative will develop standards, resources, models, and prototype multi-compartment approaches spanning maternal gut, placenta, lactating mammary epithelium, infant gut, and infant blood-brain barrier. The initiative is expected to support a mechanistic understanding of transporter function, polarity, kinetics, and transformation capacity relevant to pregnancy, lactation, infant nutrition, pediatric pharmacology, and neurodevelopment. By emphasizing multi-barrier perinatal transporter frameworks this phase of the TEN will provide community resources for future integrated studies of perinatal exposure, risk, and intervention across interlinked maternal, fetal, and infant systems. It will also strengthen coordination among investigators, accelerate dissemination of tools, and advance human-based, developmentally relevant transporter research and workforce development. The grant authority for this is 42 U.S.C. § 241

Who can apply

  • Other (see eligibility)
  • Private universities
  • Nonprofits with 501(c)(3) status
  • City or township governments
  • Independent school districts
  • Public and state universities
  • Special district governments
  • Nonprofits without 501(c)(3) status
  • Federally recognized tribal governments
  • Public and Indian housing authorities
  • Other Native American tribal organizations
  • State governments
  • Small businesses
  • County governments
  • For-profit organizations

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Agency contact

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Please contact via e-mail

nichd_opptb_nofos@mail.nih.gov
Write this proposal with Grantee
  • Reads the full solicitation and lays out every required section
  • Drafts each section with you, in your words
  • Checks the draft against every requirement before you submit
Official notice on Grants.gov

How to write it

All guides

More from NIH

All NIH funding

Get new funding every Monday

New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.

Details from Grants.gov, last updated Jul 16, 2026. Deadlines and requirements can change: always confirm them in the official notice.